Adaptive Biotechnologies Corporation — Balance Sheet (NASDAQ:ADPT) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Total assets 1.12 B923.34 M856.62 M661.13 M539.38 M512.74 M Total liabilities 373.15 M319.24 M392.52 M352.86 M336.89 M287.74 M Total equity 743.27 M604.1 M464.1 M308.28 M202.49 M225 M Total liabilities & shareholders' equities 1.12 B923.34 M856.62 M661.13 M539.38 M512.74 M Total debt ———130.66 M133.28 M131.21 M Net debt ———-116.97 M-493 K-21.27 M

News

Adaptive Biotechnologies (ADPT) Moves 5.8% Higher: Will This Strength Last?

Piper Sandler reiterates Adeptus Biotechnologies stock rating at overweight

Lo Francis, chief people officer at Adaptive Biotechnologies, sells $574k in ADPT

Adaptive Biotechnologies at TD Cowen Conference: Strategic Growth Insights

3 ‘Strong Buy’ Stocks to Buy Now, 2/6/2026, According to Top Analysts - TipRanks.com

Adaptive Biotechnologies Corporation (ADPT) Q4 2025 Earnings Call Transcript

Adeptus Biotechnologies stock price target raised to $21 by TD Cowen

Thursday’s Insider Activity: Cavco Director Buys as Execs Sell Off

Adaptive Biotechnologies Corporation 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:ADPT) 2026-02-06

Adeptus Biotechnologies stock price target raised to $22 by BTIG on strong MRD growth

Adaptive Biotechnologies (ADPT) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

Adaptive Biotechnologies (ADPT) Reports Q4 Loss, Misses Revenue Estimates